Medtronic Inc (NYSE: MDT), Omaha, NE – FDA Inspections

Inspection records and compliance data for Medtronic Inc in Omaha, Nebraska. 3 FDA inspections on record, last inspected October 09, 2013. Publicly traded as NYSE: MDT.

Company Profile

This profile covers Medtronic Inc based in Omaha, Nebraska, United States.

FDA Inspection History

FDA inspections: 3
OAI: 0
VAI: 0
NAI: 3
Form 483s: 0
Warning letters: 0

First inspected June 23, 2009. Last inspected October 9, 2013.

FDA inspections (3)

Date	Result	FDA center(s)	Insp. #
October 9, 2013	NAI	Biologics · Human Cellular, Tissue, and Gene Therapies	851385
July 5, 2012	NAI	Biologics · Human Cellular, Tissue, and Gene Therapies	789410
June 23, 2009	NAI	Biologics · Human Cellular, Tissue, and Gene Therapies	598225

FDA documents

No Form 483s, Warning Letters or EIRs on record.

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Marion, Dr Alan

KEDPlasma LLC

American Red Cross Blood Services

Innovative Blood Resources, a Division of New York Blood Center, Inc.

Jay R. Meyer, M.D.

Lions Eye Bank of Nebraska Inc

Methodist Women's Hospital

Innovative Blood Resources, A Division of New York Blood Center, Inc. d.b.a. Nebraska Community Blood Bank

CHI Health CUMC - Bergan Mercy

Roger H. Kobayashi, MD